Richard T. Kenney - 19 May 2021 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chief Medical Officer
Signature
/s/ John Harry Cross III, power of attorney
Issuer symbol
SONN
Transactions as of
19 May 2021
Net transactions value
+$15,500
Form type
4
Filing time
20 May 2021, 07:52:25 UTC
Next filing
09 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Purchase $15,500 +10,000 +40% $1.55 35,000 19 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes unvested RSUs.